Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report

Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report

Introduction: Hepatocellular carcinoma (HCC) is by far the leading malignant indication for liver transplantation (LT). Few other malignancies, including cholangiocellular carcinoma (CCC), metastases from neuroendocrine tumors (NET), and sarcomas of the liver (LSAR), also are commonly accepted indic...

Full description

Bibliographic Details
Main Authors:	Philipp Houben, Simon Schimmack, Christian Unterrainer, Bernd Döhler, Arianeb Mehrabi, Caner Süsal
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Surgery
Subjects:	liver transplantation transplant oncology hepatocellular carcinoma cholangiocellular carcinoma neuroendocrine tumor liver sarcoma liver transplantation for rare malignancies
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2021.678392/full

Similar Items

Liver Transplantation for Liver-Originated Malignancy: A Single Center Experience
by: Ramazan Kozan, et al.
Published: (2024-07-01)

Editorial: Transplant Oncology of Liver Malignancies
by: Cheng-Maw Ho
Published: (2022-01-01)

Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature
by: Susumu Eguchi, et al.
Published: (2022-09-01)

The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications—Who Is at Risk? A Collaborative Transplant Study Report
by: Vladimir J. Lozanovski, et al.
Published: (2020-05-01)

Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies
by: Alexander H. Shannon, et al.
Published: (2023-07-01)

Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation
by: Marco Dioguardi Burgio, et al.
Published: (2023-11-01)

Liver transplantation in gastroenteropancreatic neuroendocrine tumors
by: Eduardo de Souza M. Fernandes, et al.
Published: (2023-02-01)

Tratamento local do carcinoma hepatocelular como ponte para o transplante hepático
by: Alexandre Coutinho Teixeira de Freitas, et al.

Hepatic resection for primary and secondary liver malignancies
by: Heinrich Stefan, et al.
Published: (2017-03-01)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
by: Giuseppe Mamone, et al.
Published: (2023-05-01)

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
by: Jong Man Kim
Published: (2021-10-01)

Impact of Hypothyroidism on Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
by: Salman A, et al.
Published: (2021-09-01)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
by: Po-Jung Hsu, et al.
Published: (2021-10-01)

Incidental Hepatocellular Carcinoma after Liver Transplantation: Clinicopathologic Features and Prognosis
by: Fatih Ozdemir, et al.
Published: (2022-12-01)

Atezolizumab plus Bevacizumab as a Bridge for Liver Transplant in Hepatocellular Carcinoma
by: Gabriela Azevedo Solino, et al.
Published: (2023-02-01)

Case report: A rare case of intragastric metastasis after liver transplantation for liver cancer
by: Youfeng Xue, et al.
Published: (2024-12-01)

LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA
by: Gustavo Pilotto D. SÁ, et al.
Published: (2016-12-01)

Risk for Recurrence in Long-Term Follow-Up of Children after Liver Transplantation for Hepatoblastoma or Hepatocellular Carcinoma
by: Marek Stefanowicz, et al.
Published: (2024-02-01)

Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study
by: Ajacio Bandeira de Mello Brandão, et al.
Published: (2024-03-01)

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
by: Fidelman N, et al.
Published: (2019-06-01)

Preoperative Alfa-Fetoprotein and Fibrinogen Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation Regardless of the Milan Criteria: Model Development with External Validation
by: Nan Jiang, et al.
Published: (2018-07-01)

The presence of bilobar tumor should be considered as a new limit for transplantation beyond the Milan criteria? A presença de tumor bilobar deve ser considerado novo limite para exclusão de transplante em pacientes que excedem os critérios de Milão?
by: Raul Carlos Wahle, et al.
Published: (2010-03-01)

Expanding Indications for Liver Transplant: Tumor and Patient Factors
by: Kevin Ka-Wan Chu, et al.
Published: (2021-01-01)

Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
by: Stephanie M. Woo, et al.
Published: (2022-12-01)

LIVER TRANSPLANT FOR METASTATIC NEUROENDOCRINE TUMORS: A SINGLE-CENTER REPORT
by: Raquel Lima Sampaio, et al.
Published: (2023-07-01)

Clinical and laboratory parameters as predictors of long-term outcome according to the etiology of underlying chronic liver disease in patients who underwent liver transplantation for hepatocellular carcinoma treatment
by: Paulo Henrique Costa Diniz, et al.

Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience
by: Michelle R. Ju, et al.
Published: (2020-05-01)

Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
by: Brianna Ruch, et al.
Published: (2022-10-01)

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
by: Ben F.J. Goudsmit, et al.
Published: (2023-12-01)

Transplantation in hepatocellular carcinoma - controversies and recommendations: A review of current literature
by: Ruchir Bhavsar, et al.
Published: (2021-01-01)

HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS
by: Santiago RODRÍGUEZ, et al.

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
by: Kyuho Lee, et al.
Published: (2017-01-01)

Very High Dose Epinephrine for the Treatment of Vasoplegic Syndrome during Liver Transplantation
by: MB Khosravi, et al.
Published: (2013-01-01)

Liver resection and transplantation in the era of checkpoint inhibitorsKeypoints
by: Parissa Tabrizian, et al.
Published: (2024-11-01)

Peritoneal Recurrence of Initially Controlled Hepatocellular Carcinoma after Living Donor Liver Transplantation
by: Nariman Sadykov, et al.
Published: (2015-01-01)

COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL
by: Alexandre Coutinho Teixeira de FREITAS, et al.
Published: (2016-03-01)

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
by: Jingrui Wang, et al.
Published: (2023-03-01)

Low MARCO Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma Following Liver Transplantation
by: Zhang Q, et al.
Published: (2022-06-01)

Liver transplantation in an adult patient with hepatocellular carcinoma following liver cirrhosis as a complication of the Fontan procedure -A case report-
by: Min-kyung Cho, et al.
Published: (2020-10-01)

INDICATION FOR LIVER TRANSPLANTATION DUE TO HEPATOCELLULAR CARCINOMA: ANALYSIS OF 1,706 PROCEDURES OVER THE PAST DECADE IN THE STATE OF PARANÁ
by: Alexandre Coutinho Teixeira de Freitas, et al.
Published: (2022-12-01)